# The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis

> **NCT07371572** · PHASE3 · RECRUITING · sponsor: **Sint Maartenskliniek** · enrollment: 212 (estimated)

## Conditions studied

- Hand Osteoarthritis

## Interventions

- **DRUG:** 120mg methylprednisolone acetate
- **DRUG:** 40mg methylprednisolone acetate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07371572
- **Lead sponsor:** Sint Maartenskliniek
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-28
- **Primary completion:** 2028-04
- **Final completion:** 2028-11
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07371572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07371572, "The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07371572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*